14Jul/13

Dr Reddy's Labs scrip outperforms BSEHC, touches yearly high of – pharmabiz.com


pharmabiz.com

Dr Reddy’s Labs scrip outperforms BSEHC, touches yearly high of
pharmabiz.com
DRL has already pushed four biosimilars viz, rituximab, filgrastim, darbepoetin alpha and peg-filgrastim in the market. To consolidate its position in biosimilars, DRL entered into an alliance with Merck Serono, a division of Merck KGaA, Germany during

and more »

12Jul/13

Maternal Antibodies May Trigger up to 25% of Autism Cases – Medscape


Medscape

Maternal Antibodies May Trigger up to 25% of Autism Cases
Medscape
Maternal antibodies that interfere with fetal brain proteins during pregnancy may be responsible for roughly one quarter of cases of autism spectrum disorder (ASD), a new study suggests. Lead researcher Judy Van de Water, PhD, and colleagues have
Mother’s Antibodies May Explain a Quarter of Autism CasesTIME
Study ID’s link between maternal antibodies, autismWND.com
Antibodies during pregnancy linked to autismFuturity: Research News
Science Daily (press release) –Scientist –Science World Report
all 39 news articles »